流行性感冒预防和治疗方法的进展_黄琦芸.pdfVIP

( Chin J New Drugs Clin Rem) , 200 3 7 , 22 7 # 4 36 # E- m ail x yy lc@ shy yxx . com http / / x yyl . chinajour nal. net . cn http / / zg xy ylczz . periodicals . com . cn CGP 64 128A ) in patient s wit h cancer[ J ] . Clin Cancer R es, 1999, cal trials; genet ic code 5( 11) 3357- 3363. [ 20] T A M M I, DO RK EN B, HA RT M A N N G . Ant isense t herapy in [ ABSTRACT] Antisense drugs are expressien s oncology new hope f or an old idea [ J ] . Lancet , 200 1, 358 w hich can modulate t he target gene at the level of ( 9280) 489-497. gene replication, t ranscription, splicing, t ransport at ion [ 2 1] CU N N ING HAM CC, HO L M L U N D JT , SCHIL L ER JH, et al. A phase I trial of c- R af kinase antisense oligonucleot ide IS IS 5 132 and t ranslation. T hey play an antisense eff ect t hrough administered as a continous int rav enous infusion in patient s wit h int erfering the g enetic informat ion . s transferring adv anced cancer [ J] . Clin Can cer Res, 2000, 6( 5) 1626- 163 1. f rom nucleic acid t o prot ein and inhibit ing t he biolog-i [ 22] ZH OU WQ . M ix ed-backbone oligonucleot ides as second genera- cal synt hesis of protein relat ed w it h some diseases. In tion antisense drug s[ J] . Drugs Future, 2000, 25( 2) 183- 19 1. t his article, the prog ress in st udy of mech anism and clinical trials in t he lat est f ew years is review ed. Chin J N ew Drugs Clin Rem , 200 3 J ul , 22 ( 7) 43 1- 4 36 . Progress of antisense drugs research [ REFERENCES] W U Fei, L I Ke,